These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7448129)

  • 41. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
    Livio M; Rajtar G; Merino J; de Gaetano G
    Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex related differences in platelet function: the effect of aspirin.
    Kelton JG; Carter CJ; Santos A; Hirsh J
    Blood; 1982 Mar; 59(3):625-7. PubMed ID: 7059670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
    Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
    Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats.
    Livio M; Palmier C; Villa S; Maynadier B; Delhon A; Lauressergues H; de Gaetano G
    Atherosclerosis; 1981 Jul; 39(4):469-77. PubMed ID: 7259827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of action: aspirin.
    Hoak JC
    Thromb Res Suppl; 1983; 4():47-51. PubMed ID: 6415858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
    Chong BH; Grace CS; Rozenberg MC
    Br J Haematol; 1981 Dec; 49(4):531-40. PubMed ID: 7317283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-dependent inhibition of platelet cyclooxygenase by indomethacin is slowly reversible.
    Walenga RW; Wall SF; Setty BN; Stuart MJ
    Prostaglandins; 1986 Apr; 31(4):625-37. PubMed ID: 3088675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin.
    Rao GH; Johnson GJ; Reddy RK; White JG
    Prostaglandins; 1981 Nov; 22(5):761-72. PubMed ID: 6799989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-dose aspirin in pregnancy.
    Sibai BM; Mirro R; Chesney CM; Leffler C
    Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malondialdehyde Assay in the Evaluation of Aspirin Antiplatelet Effects.
    Polzin A; Dannenberg L; Schneider T; Knoop B; Naguib D; Helten C; Pöhl M; Kelm M; Zeus T; Hohlfeld T
    Pharmacology; 2019; 103(1-2):23-29. PubMed ID: 30355919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin response: Differences in serum thromboxane B2 levels between clinical studies.
    Brun C; Daali Y; Combescure C; Zufferey A; Michelson AD; Fontana P; Reny JL; Frelinger AL
    Platelets; 2016; 27(3):196-202. PubMed ID: 26270593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
    Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
    J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.